70 likes | 82 Views
Global Market Insights adds a new report Global Blood Transfusion Diagnostics Market Research Report for the period of 2023-2032 that shows the growth of the market is rising at a Steady CAGR to 2032.
E N D
Blood Transfusion Diagnostics Market by Manufacturers, Regions, Type and Application Forecast to 2032
Industry Insights • Blood Transfusion Diagnostics Market size will expand significantly over 2023-2032. • The flourishing medical device industry globally is presenting growth pathways for the market. • Many governments in developed and developing countries are investing significant amounts into medical devices to expand their healthcare infrastructure. • This, in consequence, has propelled the demand for blood transfusion diagnostic products, thus, contributing to market revenue. • To illustrate, recent IBEF estimates suggest that the medical device market in India could be worth USD 50 billion by 2025.
The overall blood transfusion diagnostics industry is classified based on product, application, end-use, and region. • The market share from the instruments segment will grow at a considerable CAGR from 2023 to 2032. Recent advancements in blood transfusion instruments have improved the safety and efficacy of the transfusion process. In fact, automated blood component separators and cell salvage devices now allow for the extraction of specific blood components, reducing the need for whole blood transfusions and minimizing the risk of adverse reactions. Moreover, a remarkable rise in people undergoing surgical procedures has increased the need for blood transfusion instruments, such as blood bags, infusion pumps, and others, driving business growth. • In terms of application, the blood transfusion diagnostics market value from the blood grouping segment will grow substantially through 2032. Consistent advancements in blood grouping are contributing to segment growth. Molecular blood group genotyping has revolutionized transfusion medicine by providing a DNA-based method for determining blood types. This technique involves identifying genetic variations and specific alleles associated with blood groups, allowing for precise and reliable blood typing.
Regional Analysis • Asia Pacific blood transfusion diagnostics industry will grow at a significant CAGR from 2023 to 2032. Growing healthcare industry, coupled with the increasing geriatric population in the region, is working in favor of industry growth. As per WHO, over 28% of people in China will be over 60 years of age by 2040. • Competitive Analysis • Abbott Laboratories, BAG Healthcare GmBH, Bio-Rad Laboratories, Inc, Danaher Corporation, DiagnosticaStago, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic, Inc., Immucor Inc., Merck KGaA, Ortho Clinical Diagnostics, Quotient Ltd and Thermo Fisher Scientific Inc. among others.
Blood Transfusion Diagnostics Market @ https://www.gminsights.com/industry-analysis/blood-transfusion-diagnostics-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/5607 Request for customization @ https://www.gminsights.com/roc/5607
Stay In Touch Social Media:
THANK YOU www.gminsights.com